中國生物科技服務(08037.HK)部分贖回本金500萬美元可換股債
格隆匯5月27日丨中國生物科技服務(08037.HK)發佈公吿,該公吿日期前,概無任何可換股債券已經獲公司贖回或轉換為換股股份。公司已經向認購人發出贖回通知,按518.65萬美元的適用贖回金額部分贖回本金為500萬美元(即尚未償還本金總額1000萬美元的50%)的尚未償還可換股債券。2021年5月27日,公司已經按該適用贖回金額贖回該本金額。部分贖回完成後,餘下尚未償還可換股債券的本金為500萬美元。
部分贖回後,認購人將會籤立一份部分解除契據,以解除264,750,273股股份(即公司擔保人根據股份抵押抵押予認購人的一半已抵押股份)的抵押。部分解除後,公司擔保人所持有而仍然受股份抵押所限的股份數目為264,750,273股股份。
公吿表示,公司就部分贖回所應支付的適用贖回金額已以其內部資源以現金償付。部分贖回提供良機,讓集團可以更靈活地管理其資本結構以及降低融資成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.